Activated Protein C (APC) is a regulator of the coagulation cascade, by specifically inactivating factors Va and VIIIa, in the presence of phospholipids and calcium.
In most of the cases (more than 90%), Activated Protein C Resistance (APCR) phenotype is caused by a Factor V gene mutation (Factor V Leiden). The mutation, located on Factor V exon 10 (1691 G --> A), of arginine to glutamine on position 506, renders Factor Va resistant to the cleavage by Activated Protein C. This genetic anomaly can be evidenced with a clotting method performed in the presence or the absence of Activated Protein C.
Activated Protein C Resistance is tested by using a clotting method performed with or without Activated Protein C.
| Product | Method/Application | Packaging | CAT # |
|---|---|---|---|
| Chromogenix Coatest APC Resistance - V | Clotting / IVD | 1 kit, 80-160 determinations | K823120 (823120) |
| Chromogenix Coatest APC Resistance - VS | Clotting / IVD | 1 kit, 40-80 determinations | K823138 (823138) |
| Chromogenix Coatest APC Resistance | Clotting / IVD | 1 kit, 80-160 determinations | K822643 (822643) |
| Chromogenix Coatest APC Resistance Control Plasma Level 1 | Control / IVD | 1 box (5 x 1 ml) | C822650 (822650) |
| Chromogenix Coatest APC Resistance Control Plasma Level 2 | Control / IVD | 1 box (5 x 1 ml) | C822668 (822668) |
| Chromogenix Coatest APC Resistance V DEF Plasma | Deficient Plasma / IVD | 1 box (5 x 4 ml) | B823146 (823146) |
| DiaPharma Factor V-L (Act PC-r) (DISCONTINUED) | Clotting / RUO | 1 kit, 4 x 40 determinations | DPGC061K |
| DiaPharma Factor V-L (Act PC-r) (DISCONTINUED) | Clotting / RUO | 1 kit, 4 x 20 determinations | DPGC061L |
| Biophen Act. PC-r Control Plasma (DISCONTINUED) | Control / RUO | 12 x 0.5 ml | 223405 |